Add this topic to your myFT Digest for news straight to your inbox
New molecule proves effective in animals against several drug-resistant bacteria
Investing in new oncology drugs without building up an effective arsenal against infections is a false economy
Medical experts call for curbs on agricultural fungicides
Potential remedy targets leading antibiotic-resistant pathogen that causes life-threatening infections in patients
Economic and political fallout from war distracts governments from health threats
Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments
Drug resistance is not just a problem with bacteria
New model aims to reduce high development costs and increase number of drugs being tested
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
Antimicrobial resistance already kills millions and is projected to get worse. But there is little incentive for Big Pharma to tackle the issue
As the antibiotic pipeline empties, a fresh approach to studying bacteria has emerged
Awareness about the negative impact of antimicrobial resistance on shareholder returns is growing
Health department to spend £210mn to track deadly superbugs across Asia and Africa
Research finds superbugs increase in tandem with levels of small particulate matter in the air
Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales
As McDonald’s is targeted, governments also need to tighten and enforce rules
Governments and some pharma companies try to tackle problem linked with drug resistance
Legal & General and Amundi say antimicrobial resistance poses a wider economic threat
Also in today’s newsletter, investors look to the next health crisis on the horizon
Some of the world’s biggest health challenges do not lend themselves to conventional investment
Experts believe bacteriophages could be crucial extra tool
Manufacturers struggle to keep pace with post-pandemic demand as dozens of countries report low supply of drugs
Medicines are often given for viral infections such as flu, for which they are useless, but can cause side effects
Few countries have well funded plans to tackle health threat to millions
Industry cautiously optimistic amid bipartisan support for US Pasteur bill
UK Edition
